• Pharmacokinetics of CSBTA in MASH: Impact of Disease State o

  2026-07-29

  This study systematically dissects how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a high-fat, high-cholesterol diet mouse model. Findings provide mechanistic insight into the modulation of drug metabolizing enzymes and transporters, underpinning the need for tailored dosing strategies in MASH treatment.

• GDC-0941: Precision PI3K Inhibition in Cancer Stem Cell Rese

  2026-07-28

  Explore the unique potential of GDC-0941 as a PI3K inhibitor targeting cancer stem cell-driven drug resistance. This in-depth analysis reveals new perspectives for translational oncology beyond standard proliferation assays.

• ECL Chemiluminescent Substrate Detection Kit: Precision in W

  2026-07-28

  The ECL Chemiluminescent Substrate Detection Kit by APExBIO delivers robust, ultrasensitive HRP-based detection for both protein and nucleic acid targets. Its optimized luminol-based reaction supports reproducible results, even in challenging Western blot and chemiluminescent immunoassay workflows.

• BKT140 (BL-8040): CXCR4 Antagonist for Precision Oncology

  2026-07-27

  BKT140 (BL-8040) is a potent, orally bioavailable CXCR4 antagonist that inhibits tumor cell migration and supports hematopoietic stem cell mobilization. Its high solubility and purity enable precise application in oncology research workflows. The compound's efficacy and pharmacokinetics are supported by preclinical and clinical evidence.

• AAPH as a Precision Tool for Food Protein Oxidation Modeling

  2026-07-27

  Explore how AAPH (2,2'-Azobis(2-methylpropionamidine) dihydrochloride) enables reproducible, mechanistically distinct oxidative modification of food proteins—revealing deeper assay insights beyond classical lipid peroxidation models.

• LY2228820: Precision p38 MAP Kinase Inhibitor for Advanced R

  2026-07-26

  LY2228820 delivers highly selective, dual-action inhibition of p38α/β MAPK, enabling researchers to dissect kinase-driven pathways in both cancer and anti-inflammatory models with unprecedented clarity. Robust solubility, well-characterized mechanism, and validated in vitro and in vivo applications make it the preferred tool for advancing translational studies.

• Resiquimod (R-848) in Hydrogel-Enabled Cancer Immunotherapy

  2026-07-25

  Resiquimod (R-848) is revolutionizing cancer immunotherapy workflows through its potent TLR7/8 agonist action—now with advanced delivery via injectable hydrogels. This article dissects experimental protocols, troubleshooting strategies, and translational advantages, drawing on recent innovations in programmable chemo-immunomodulation.

• Epacadostat (INCB024360): Accelerating Precision in Immune M

  2026-07-24

  Explore the mechanistic and translational potential of Epacadostat (INCB024360), a potent IDO1 inhibitor, in dissecting immunometabolic crosstalk. This article delivers protocol-centric insights, strategic guidance for translational researchers, and a forward-looking perspective on integrating standardized metabolic modulation into immuno-oncology workflows. Drawing from the latest evidence and leveraging APExBIO’s advanced product intelligence, we illuminate how targeted manipulation of tryptophan catabolism can redefine the boundaries of immune response analysis and therapeutic innovation.

• Rottlerin as a PKC Inhibitor: Workflows, Use Cases, and Trou

  2026-07-24

  Rottlerin stands out as a selective PKCδ inhibitor, enabling researchers to dissect apoptosis, cell proliferation, and host-pathogen interactions with precision. This article showcases advanced workflows, troubleshooting strategies, and novel insights from recent studies that position Rottlerin as an essential tool in cellular and translational research.

• Polybrene in Translational Research: Mechanism and Strategy

  2026-07-23

  This article offers a thought-leadership perspective for translational researchers on leveraging Polybrene (Hexadimethrine Bromide) 10 mg/mL to accelerate gene delivery and molecular biology workflows. It contextualizes Polybrene’s mechanistic role in viral gene transduction, lipid-mediated DNA transfection, and peptide sequencing, with actionable guidance for workflow design and strategic integration, while bridging recent findings from targeted protein degradation (TPD) research.

• Unraveling the Complete Nicotine Biosynthesis Pathway in Pla

  2026-07-23

  Chang et al. (2026) achieved the first complete reconstruction of nicotine biosynthesis in tobacco, identifying a vacuolar five-component metabolon and critical glycosylation/deglycosylation steps that enable stereoselective ring coupling. These findings provide a foundational platform for precise metabolic engineering of alkaloid biosynthesis and facilitate the transfer of nicotine production pathways into heterologous plant systems.

• Translating NLRP3 Biology: MCC950 Sodium from Bench to Bedsi

  2026-07-22

  A thought-leadership article for translational researchers, exploring how MCC950 sodium (CRID3 sodium salt) is revolutionizing the study of NLRP3 inflammasome biology, providing strategic guidance for modeling inflammatory and autoimmune disease, and bridging the mechanistic and practical gaps between preclinical research and clinical translation.

• HBsAg Suppresses Interferon and Triggers Autophagy via TBK1

  2026-07-22

  This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) directly manipulates TANK-binding kinase 1 (TBK1), resulting in the suppression of type I interferon responses and early autophagy induction. The findings clarify how HBV evades innate immunity and contributes to viral persistence, providing new leads for antiviral research targeting immune and autophagic pathways.

• Discovery of a PRC2 Subunit Essential for Subtelomeric Silen

  2026-07-21

  McNaught et al. identify an accessory subunit (PAS/NCU04278) of PRC2 in Neurospora crassa, essential for H3K27 methylation at subtelomeric regions. This finding advances understanding of how PRC2 distribution and gene repression are regulated in fungi, with implications for chromatin biology and epigenetic research.

• Peripheral Macrophages Drive Pain Sensitization in Chronic H

  2026-07-21

  Chivers et al. provide compelling evidence that peripheral macrophage recruitment is a key driver of persistent pain in a mouse model of chronic intermittent hypoxia, which mimics obstructive sleep apnea. Their findings illuminate immune-mediated mechanisms of nociceptor priming and highlight new avenues for targeted intervention in sleep disorder-associated chronic pain.

455 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page